The Procalcitonin and Survival Study (PASS-studiet)

PASS-studiet var et randomiseret, enkeltblindet, multicenterstudie for at undersøge om daglige Procalcitonin målinger og umiddelbar diagnostisk og terapeutisk respons på abnorme Procalcitonin værdier, kan mindske dødeligheden hos intensivpatienter.

The PASS Study was a randomized, single-blinded, multicenter trial to investigate if clinical management guided by daily standardized Procalcitonin measurements can reduce the mortality in critically ill patients.

PASS - Recruitment Complete

PASS Protocol published in BMC Infectious Diseases on 13 July 2008

Investigator website: identifier: NCT00271752